These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 8721524)

  • 1. Histamine releasability of basophils and skin mast cells in chronic urticaria.
    Zuberbier T; Schwarz S; Hartmann K; Pfrommer C; Czarnetzki BM
    Allergy; 1996 Jan; 51(1):24-8. PubMed ID: 8721524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus.
    Lourenço FD; Azor MH; Santos JC; Prearo E; Maruta CW; Rivitti EA; Duarte AJ; Sato MN
    Br J Dermatol; 2008 May; 158(5):979-86. PubMed ID: 18341658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma.
    Bischoff SC; Zwahlen R; Stucki M; Müllner G; de Weck AL; Stadler BM; Dahinden CA
    Int Arch Allergy Immunol; 1996 Jul; 110(3):261-71. PubMed ID: 8688673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular signal-regulated kinases regulate leukotriene C4 generation, but not histamine release or IL-4 production from human basophils.
    Miura K; Schroeder JT; Hubbard WC; MacGlashan DW
    J Immunol; 1999 Apr; 162(7):4198-206. PubMed ID: 10201947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming and inducing effects of interleukin-3 on histamine release from cord-blood basophils.
    Miadonna A; Salmaso C; Marco MP; Pugni L; Milazzo N; Tedeschi A; Marini A
    Allergy; 1997 Oct; 52(10):992-8. PubMed ID: 9360750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential modulation of mediator release from human basophils and mast cells by mizolastine.
    Triggiani M; Giannattasio G; Balestrieri B; Granata F; Gelb MH; de Paulis A; Marone G
    Clin Exp Allergy; 2004 Feb; 34(2):241-9. PubMed ID: 14987304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
    Brunner T; de Weck AL; Dahinden CA
    J Immunol; 1991 Jul; 147(1):237-42. PubMed ID: 1711077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria.
    Sabroe RA; Francis DM; Barr RM; Black AK; Greaves MW
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):651-8. PubMed ID: 9802375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of chronic urticaria.
    Kaplan AP; Greaves M
    Clin Exp Allergy; 2009 Jun; 39(6):777-87. PubMed ID: 19400905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli.
    Luquin E; Kaplan AP; Ferrer M
    Clin Exp Allergy; 2005 Apr; 35(4):456-60. PubMed ID: 15836753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyzing histamine release by flow cytometry (HistaFlow): a novel instrument to study the degranulation patterns of basophils.
    Ebo DG; Bridts CH; Mertens CH; Hagendorens MM; Stevens WJ; De Clerck LS
    J Immunol Methods; 2012 Jan; 375(1-2):30-8. PubMed ID: 21945198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective inhibition of sodium on basophil histamine release in patients with allergic rhinitis and bronchial asthma.
    Tedeschi A; Cottini M; Salmaso C; Milazzo N; Miadonna A
    Eur Respir J; 1996 Oct; 9(10):2070-6. PubMed ID: 8902469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin augments IgE-mediated histamine release from human peripheral basophils via Syk kinase activation.
    Matsuo H; Yokooji T; Morita H; Ooi M; Urata K; Ishii K; Takahagi S; Yanase Y; Hiragun T; Mihara S; Hide M
    Allergol Int; 2013 Dec; 62(4):503-11. PubMed ID: 24153330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human basophil releasability. III. Genetic control of human basophil releasability.
    Marone G; Poto S; Celestino D; Bonini S
    J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionic regulation of human basophil releasability. III. Effects of Na+ and Ca2+ on histamine release induced by different stimuli.
    Tedeschi A; Palella M; Arquati M; Milazzo N; Miadonna A
    Pharmacol Res; 1994; 30(3):229-41. PubMed ID: 7532302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of mechanisms of IL-3 induced histamine release and IL-3 priming effect on human basophils.
    Okayama Y; Begishvili TB; Church MK
    Clin Exp Allergy; 1993 Nov; 23(11):901-10. PubMed ID: 10779277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine release in idiopathic cold urticaria.
    Asero R; Tedeschi A; Lorini M
    Allergy; 2002 Dec; 57(12):1211-2. PubMed ID: 12464056
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic urticaria: novel clinical and serological aspects.
    Asero R; Tedeschi A; Lorini M; Salimbeni R; Zanoletti T; Miadonna A
    Clin Exp Allergy; 2001 Jul; 31(7):1105-10. PubMed ID: 11468002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis.
    Marone G; Giugliano R; Lembo G; Ayala F
    J Invest Dermatol; 1986 Jul; 87(1):19-23. PubMed ID: 2425005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.